HistoSonics, Inc. is pioneering a novel, non-invasive therapeutic platform based on histotripsy, a focused ultrasound technology that mechanically destroys targeted tissue without surgery, heat, or radiation. Its Edison® System enables precise, image-guided tumor destruction—beginning with liver tumors—offering the potential for safer, outpatient treatment and faster recovery. HistoSonics is redefining the standard of care in interventional oncology through breakthrough acoustic energy technology.